Accession Number: | 0000899243-20-021009 |
Date: | 2020-07-31 |
Issuer: | SOLENO THERAPEUTICS INC (SLNO) |
Original Submission Date: |
COLLINSON STUART J
203 REDWOOD SHORES PKWY, STE 500
REDWOOD CITY, CA 94065
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-31 | A | 1,018 | a | $1.72 | 1,018 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reported securities are represented by restricted stock units ("rsus"). each rsu represents a contingent right to receive one share of slno common stock. the rsus fully vest on july 31, 2020. the rsus are for the benefit of, and ultimately will be transferred to, forward ventures v, l.p. of which the reporting person serves as a managing member. |